Published in Cardiovasc Res on January 01, 1995
Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol (2011) 1.38
The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol (2000) 1.22
Placental growth factor mediates aldosterone-dependent vascular injury in mice. J Clin Invest (2010) 1.17
Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Arterioscler Thromb Vasc Biol (2013) 1.04
Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways. Arterioscler Thromb Vasc Biol (2011) 1.04
Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease. Pflugers Arch (2013) 0.86
Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization. Am J Physiol Heart Circ Physiol (2011) 0.83
Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice. Endocrinology (2012) 0.81
Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications. Curr Hypertens Rep (2014) 0.80
Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors. PLoS One (2014) 0.75
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet (2001) 8.54
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 2.70
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg (1998) 2.58
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev (1996) 2.43
Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol (1998) 2.27
Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty. Circulation (2001) 2.26
Localization of 5-HT(6) receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res (2000) 2.13
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history and the effect of thrombolysis. Circulation (1998) 2.07
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation (1995) 2.07
The challenges of conducting clinical research: one research team's experiences. Clin Nurse Spec (2001) 2.05
MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer (1997) 2.04
Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol (2000) 2.03
Neurotransmitter transporters in the central nervous system. Pharmacol Rev (1999) 1.98
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes (2002) 1.91
Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci U S A (2001) 1.88
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation (1997) 1.80
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev (1999) 1.74
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66
Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation (1982) 1.62
The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J (2002) 1.58
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest (1996) 1.57
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
[Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist]. Rev Mal Respir (1996) 1.48
Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J (1996) 1.47
Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol (2001) 1.47
Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group. Eur Heart J (1997) 1.45
Percutaneous aspiration of a coronary thrombus. Cathet Cardiovasc Diagn (1989) 1.44
Hypersensitivity of human coronary segments to ergonovine 6 months after injury by coronary angioplasty: a quantitative angiographic study in consecutive patients undergoing single-vessel angioplasty. Eur Heart J (1996) 1.43
The scourge of coronary disease in diabetic patients: will antibiotics sweeten the pill? Eur Heart J (2002) 1.41
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Eur Heart J (1996) 1.41
HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol (2001) 1.41
Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J (1996) 1.40
Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock. Crit Care Med (1997) 1.40
Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS Lett (1997) 1.39
CGRP receptor blockade by MK-8825 alleviates allodynia in infraorbital nerve-ligated rats. Eur J Pain (2014) 1.39
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol (1996) 1.39
Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction. Circulation (1997) 1.38
[Determination of mannitol and lactulose in urine by capillary gas chromatography]. Ann Biol Clin (Paris) (1992) 1.38
Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma. Lancet (1989) 1.38
Combined effects of inhaled nitric oxide and hyperoxia on pulmonary vascular permeability and lung mechanics. Crit Care Med (1999) 1.38
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry (2011) 1.37
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol (1985) 1.37
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res (1999) 1.37
Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci (2001) 1.36
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci (2001) 1.33
Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci (1986) 1.31
Carotid-cavernous fistulas: diagnosis with spiral CT angiography. AJNR Am J Neuroradiol (2000) 1.29
Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci (2000) 1.29
Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int (1995) 1.22
Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation (1997) 1.21
Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol Psychiatry (2007) 1.19
Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol (1995) 1.18
Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience (1999) 1.18
Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol (1998) 1.17
Serotonin and tolerance to delay of reward in rats. Psychopharmacology (Berl) (1999) 1.16
Characterization of a progesterone-binding, three-domain antibody fragment (VH/K) expressed in Escherichia coli. Immunology (1995) 1.16